Stockscreener 앱 받기
3.005
1.31%
-0.04
시간 외 거래:
3.06
0.055
+1.83%
전일 마감가:
$3.045
열려 있는:
$3.06
하루 거래량:
82,081
Relative Volume:
0.35
시가총액:
$108.37M
수익:
-
순이익/손실:
-
주가수익비율:
-1.5189
EPS:
-1.9784
순현금흐름:
-
1주 성능:
-2.12%
1개월 성능:
-26.17%
6개월 성능:
-48.89%
1년 성능:
+0.00%
1일 변동 폭
$2.99
$3.2353
1주일 범위
$2.85
$3.2354
52주 변동 폭
$2.34
$8.79
Anteris Technologies Global Corp Stock (AVR) Company Profile
명칭
Anteris Technologies Global Corp
전화
651-493-0606
주소
860 BLUE GENTIAN ROAD, EAGAN
AVR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
3.005 | 114.50M | 0 | 0 | 0 | -1.9784 |
|
ISRG
Intuitive Surgical Inc
|
516.12 | 185.10B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
175.33 | 50.76B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.16 | 43.19B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
261.07 | 37.26B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
210.08 | 16.13B | 2.90B | 467.20M | 306.90M | 6.37 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-08 | 개시 | Lake Street | Buy |
| 2025-01-07 | 개시 | Barclays | Overweight |
| 2025-01-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-01-07 | 개시 | TD Cowen | Buy |
Anteris Technologies Global Corp 주식(AVR)의 최신 뉴스
What analysts say about Anteris Technologies Global Corp. stockHigh-velocity capital appreciation - Autocar Professional
What drives Anteris Technologies Global Corp. stock priceFree Stock Market Mentorship - PrintWeekIndia
Is Anteris Technologies Global Corp. a good long term investmentExplosive wealth accumulation - jammulinksnews.com
Anteris Technologies Global Corp. Stock Analysis and ForecastFree Predictions - jammulinksnews.com
How Anteris Technologies Global Corp. stock reacts to Fed policy changesSmart Growth Low Risk Picks - Newser
Why Anteris Technologies Global Corp. stock attracts strong analyst attentionFree Stock Market Courses - Newser
What makes Anteris Technologies Global Corp. stock price move sharplyPro Trader Stock Focus - Newser
Anteris Technologies Announces Cessation of Securities - TipRanks
Anteris Technologies Updates CDI Issuance for June 2025 - TipRanks
Anteris Technologies Global (ASX:AVR shareholders incur further losses as stock declines 15% this week, taking three-year losses to 72% - simplywall.st
Anteris Technologies Global (ASX:AVR) investors are sitting on a loss of 66% if they invested three years ago - Yahoo
FY2026 Earnings Forecast for AVR Issued By Cantor Fitzgerald - Defense World
Anteris Technologies Strengthens Board with Key Appointments - MSN
Anteris appoints David Roberts, Gregory Moss to its Board - Medical Buyer
Anteris Technologies Announces Director Departure - TipRanks
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors - The Manila Times
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors - GlobeNewswire Inc.
Kalkine: Leadership Reshuffle at Anteris (ASX:AVR) Highlights Strategic Growth Amid ASX200 Momentum - Kalkine Media
anteris technologies appoints new board members and announces resignation By Investing.com - Investing.com South Africa
Anteris Technologies Appoints New Board Members - TipRanks
anteris technologies appoints new board members and announces resignation - Investing.com
Anteris Technologies Expands CDI Issuance in Strategic Securities Adjustment - TipRanks
Analyzing MSA Safety (NYSE:MSA) & Anteris Technologies Global (NASDAQ:AVR) - Defense World
Anteris Technologies Global Corp’s Lock-Up Period Set To End on June 11th (NASDAQ:AVR) - Defense World
Millennium Management LLC Purchases Shares of 313,298 Anteris Technologies Global Corp (NASDAQ:AVR) - Defense World
Will Anteris' DurAVR Spark A Paradigm Shift In The Transcatheter Aortic Valve Replacement Landscape? - RTTNews
Citadel Advisors LLC Makes New Investment in Anteris Technologies Global Corp (NASDAQ:AVR) - Defense World
Critical Survey: Anteris Technologies Global (NASDAQ:AVR) and Vicarious Surgical (NYSE:RBOT) - Defense World
Anteris Technologies advances toward PARADIGM trial after key regulatory and clinical milestones - Proactive financial news
Anteris Technologies Issues New Employee Incentive Securities - TipRanks
Anteris scales for pivotal PARADIGM Trial, plunging R&D investment into clinical activities - Proactive financial news
The morning catch up: ASX to extend gains as global optimism lifts markets - Proactive financial news
Anteris Technologies Advances Clinical Trial Efforts with DurAVR® THV - TipRanks
Anteris Technologies Global Corp (AVR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.28%
자본화:
|
볼륨(24시간):